ABSTRACT: Phosphoinositide 3-kinase c(PI3Kc) is a critical mediator of directional cell movement. Here, we sought to characterise the role of PI3Kc in mediating the different steps of polymorphonuclear leukocyte (PMN) trafficking in the lung.
space was reduced in these mice. When irradiated PI3Kc
-/-mice were reconstituted with bone marrow from wild-type mice, migratory activity into the alveolar space was restored partially. A small-molecule PI3Kc inhibitor reduced chemokine-induced PMN migration in vitro when PMNs or epithelial cells, but not when endothelial cells, were treated. The inhibitor also reduced LPSinduced PMN migration in vivo.
We conclude that PI3Kc is required for transepithelial but not for transendothelial migration in LPS-induced lung injury. Inhibition of PI3Kc activity may be effective at curbing excessive PMN infiltration in lung injury.
KEYWORDS: Acute lung injury, chemotaxis, inflammation, polymorphonuclear leukocytes, transmigration R ecruitment of polymorphonuclear leukocytes (PMNs) to inflamed tissues is an essential requirement of the innate immune response but can lead to organ damage when excessive and uncontrolled. In the lung, excessive PMN infiltration can result in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), a condition that can follow pneumonia, acid aspiration, major trauma or sepsis, and causes ,75,000 deaths per year in the USA alone [1] . Depletion of PMNs curbs experimental lung damage [2] but is not desirable in most patients because it induces impaired host defence. Although the pathogenicity of PMNs in ALI/ARDS has been impressively demonstrated, molecular mechanisms underlying PMN trafficking in the lung remain poorly understood [3] . This may explain why, to this day, there is no strategy for the modulation of PMN infiltration in humans and no therapy available for ALI/ARDS beyond mechanical ventilation and other supportive approaches [4] . The mortality of ARDS remains high at 35-40% [5] .
Pulmonary infiltration with inflammatory leukocytes is initiated by activation of circulating PMNs, resulting in altered mechanical properties and enhanced migratory activity [6] . Initial contact between PMNs and pulmonary endothelium requires adhesion molecules in some ARDS models [7] , but not in others [8] . Once activated PMNs adhere to the pulmonary capillaries, additional steps are required to initiate transendothelial migration into the lung interstitium and transepithelial migration into the alveolar space, including activation of chemokine receptors and structural rearrangement of adhesion molecules [9] . Cytoskeletal reorganisation of PMNs, and endothelial and epithelial cells is a prerequisite to facilitate directional movement of leukocytes to the lung.
The family of class I phosphoinositide 3-kinases (PI3Ks) are isoforms of heterodimeric lipidmodifying proteins that are involved in the regulation of numerous cell functions, including cell growth, proliferation, adhesion, motility and survival [10] . PI3Kc is a class IB PI3K, consisting of a p110c catalytic subunit and a 101-kD regulatory subunit (p101). PI3Kc signalling is found downstream of different receptor types, including G protein-coupled chemokine receptors. Activation of chemokine receptors leads to the release of the G protein subunit bc that associates with the p110 adaptor protein and initiates translocation of PI3Kc to the cell membrane, where it mediates the phosphorylation of posphatidylinositol (PI) 3,4-bisphosphate to PI 3,4,5-trisphosphate [11] . PI 3,4,5-trisphosphate is an essential mediator of cell orientation and directional cell movement [12] , thus making PI3Kc a promising target in leukocyte-dependent inflammatory diseases [13] .
Involvement of PI3Kc in ALI has been implicated but study results have been ambiguous. In a model of ventilator-induced lung injury, PI3Kc gene-deficient (PI3Kc -/-) mice exhibited improved lung mechanics and reduced formation of hyaline membranes while release of chemotactic cytokines in the lung was unaltered [14] . In the same model, others demonstrated an attenuation in the activation of nuclear factor (NF)-kB in inflammatory cells and a decrease in the release of inflammatory cytokines in mice pretreated with a nonselective PI3K inhibitor [15] . In contrast, PI3Kc -/-mice were more susceptible to acute lung injury induced by intraperitoneal administration of Escherichia coli [16] or intratracheal application of pneumococcal virulence factor pneumolysin [17] . Pretreatment with the nonselective PI3K inhibitor wortmannin increased serum levels of pro-inflammatory cytokines and increased mortality in another sepsis model [18] . In different models of ALI, PMN recruitment and infiltration into the lungs of PI3Kc -/-mice was found to be attenuated [19] , increased [16] or similar [17] to wild-type mice. It is important to recognise that, in all these studies, single steps of PMN trafficking in the lung were not differentiated.
Functional expression of PI3Kc in endothelial cells has recently been demonstrated and suggested to mediate selectin-dependent adhesion of leukocytes [19] . Whether PI3Kc on pulmonary microvascular endothelial or epithelial cells is involved in adhesion or transmigration is unknown.
The current study was designed to elucidate the role of PI3Kc for the different steps of PMN trafficking in the lung, i.e. recruitment from the peripheral blood and adherence to the pulmonary capillaries, transendothelial migration into the lung interstitium, and transepithelial migration into the alveolar space. We used gene-deficient mice and a selective smallmolecule inhibitor to block PI3Kc function in vitro and in vivo. We created bone marrow chimeras to study PI3Kc effects on haematopoietic versus nonhaematopoietic cells. Our results demonstrate a specific role of PI3Kc in transepithelial neutrophil migration during ALI that might help to interpret conflicting results from previous studies.
MATERIALS AND METHODS

Mice
Wild-type male C57Bl/6 mice were obtained from Jackson Labs (Bar Harbor, ME, USA). Breeder pairs of PI3Kc genedeficient mice (PI3Kc -/-, C57Bl/6 background) were provided by D. Wu at the University of Connecticut (Farmington, CT, USA). Mice were bred, and deletion of the p110 subunit of PI3Kc was confirmed by PCR [20] . Wild-type littermates (PI3Kc +/+ ) served as control animals. All animal experiments were approved by the Animal Care and Use Committee of the University of Virginia (Charlottesville, VA, USA). Mice were 8-12 weeks of age.
Differential blood cell counts
Increased blood cell counts in gene-deficient mice with targets that alter cell transmigration have been described [21] and will influence the analysis of migratory activity. To reveal possible differences between the different groups of mice, baseline differential blood counts were performed in PI3Kc +/+ and PI3Kc -/-mice using an automatic analyser (Hemavet 850 FS; CDC Technologies, Oxford, CT, USA).
Generation of chimeric mice
Chimeric mice were generated by transferring bone marrow between PI3Kc
+/+ and PI3Kc -/-mice as described previously [22] . Briefly, recipient mice were lethally irradiated in two doses of 600 rad each (separated by 4 h). This regimen results in .90% donor-derived neutrophils at 6 weeks of reconstitution. Bone marrow from donor mice was harvested from both femora and tibiae, and ,5 million cells were injected intravenously into recipient mice. Bone marrow transplantation (BMT) was performed in four groups of mice: 1) bone marrow from PI3Kc -/-into PI3Kc +/+ (chimeric mice express PI3Kc on nonhaematopoietic cells only); 2) bone marrow from PI3Kc +/+ into PI3Kc -/-(chimeric mice express PI3Kc on haematopoietic cells only); 3) bone marrow from PI3Kc -/-into PI3Kc -/-; and 4) bone marrow from PI3Kc +/+ into PI3Kc
. Mice in groups 3 and 4 served as negative and positive controls for possible radiation effects. Chimeric mice were used for experiments 6 weeks after BMT.
Small-molecule PI3Kc inhibitor
We evaluated the small-molecule PI3Kc inhibitor AS-605240 (5-quinoxalin-6-ylmethylene-thiazolidine-2,4-dione) (Merck Serono, Geneva, Switzerland) [23] for its efficiency to block PMN transmigration in vitro and in vivo. AS-605240 selectively inhibits PI3Kc enzymatic activity, PI3Kc-mediated downstream signalling and chemotaxis [23] . Stock solutions were prepared in 0.5% carboxymethyl cellulose (CMC) and 0.25% Tween 20 in saline and used at indicated concentrations.
In vitro transendothelial migration
To test whether inhibition of neutrophil PI3Kc is important in regulating migration, we conducted in vitro transmigration studies with PMNs and pulmonary endothelial cells (PECs) so that we could treat the cell types separately with AS-605240. PECs were harvested from wild-type male C57Bl/6 mice using a positive immunomagnetic selection for CD31 (Mec 13. PMNs from C57Bl/6 or PI3Kc -/-mice were isolated from bone marrow using a three layer Percoll gradient (78, 66, and 54%) as previously described [9] . This technique yielded a cell purity of .90%. PMNs, endothelial cells or both were incubated with AS-605240 at 15 mM for 30 min. This concentration has been previously shown to significantly reduce monocyte chemotactic protein-1-induced migration of mouse monocytes [23] . Negative controls were treated with vehicle only (CMC 0.5% and Tween 20 0.25% in saline). For the final 15 min, PMNs were labelled with calcein AM (5 mM; Molecular Probes, Carlsbad, CA, USA) and washed twice. Filters were moved to outer wells containing 400 mL of phenol-free DMEM with or without chemokine (CXC motif) ligand (CXCL)2/3 (macrophage inflammatory protein-2, 200 ng?mL -1 ; PeproTech Inc., Rocky Hill, NJ, USA). 2.5610 5 PMNs were plated on filters with or without endothelial cells. Filters were incubated for 2 h at 37uC and fluorescence was measured in the bottom wells (excitation 485 nm; emission 530 nm).
In vitro transendothelial and transepithelial migration of human cells
PMNs from healthy donors were isolated by a two-layer Percoll gradient (72% and 63%) as previously described [24] . The purity of the resulting cell population was .95%. Human A549 pulmonary epithelial cells (American Type Culture Collection, Manassas, VA, USA) were grown in RPMI containing 10% FBS, 1% epithelial cell growth supplement, and 1% penicillin/streptomycin solution. 100,000 epithelial cells were seeded on the collagen-coated undersurface of inverted Transwell filters and allowed to adhere for 2 h at 37uC in a humidified 5% CO 2 incubator. Nonadherent cells were removed, filters were moved to wells containing culture medium, and cells were incubated for 72 h until a confluent monolayer was formed [25] . PMNs, A549 cells or both were incubated with AS-605240 at 15 mM for 30 min, and migratory activity was determined as described above. Negative controls were treated with vehicle only (CMC 0.5% and Tween 20 0.25% in saline). In additional experiments, human pulmonary microvascular endothelial cells (HPMECs) (ScienCell Research Laboratories, Carlsbad, CA, USA) were plated on fibronectin-coated filters in a Transwell system, and transmigration of human PMNs was assessed as described above.
Murine model of ALI Up to four mice were exposed to aerosolised lipopolysaccharide (LPS) in a custom-built cylindrical chamber (2069 cm) connected to an air nebuliser (MicroAir; Omron Healthcare, Vernon Hills, IL, USA). LPS from Salmonella enteritidis (Sigma Co.) was dissolved in 0.9% saline (500 mg?mL -1 ) and mice inhaled LPS for 30 min. As previously shown, this mimics several aspects of ALI, including PMN recruitment into all compartments of the lung, increase in vascular permeability [26] , release of chemokines and disruption of the pulmonary architecture [27] . Control mice were exposed to saline aerosol.
In vivo inhibition of PI3Kc
To evaluate PMN migration in vivo, wild-type and PI3Kc -/-mice were intraperitoneally injected with AS-605240 1 h prior to LPS exposure. The inhibitor was used at a concentration of 50 mg?kg -1 as previously suggested [23] . Control mice received vehicle only (CMC 0.5% and Tween 20 0.25% in saline).
PMN trafficking in the lung PMN recruitment into the different compartments of the lung (pulmonary vasculature, interstitium, alveolar airspace) was assessed as previously described [26] . Briefly, 24 h after LPS exposure (peak of LPS-induced accumulation of PMNs in the bronchoalveolar lavage fluid (BALF)), intravascular PMNs were labelled by an i.v. injection of Alexa 633-labelled GR-1. After 5 min, mice were euthanised and nonadherent PMNs were removed from the pulmonary vasculature by flushing 10 mL of PBS at 25 cmH 2 O through the spontaneously beating right ventricle. BALF was withdrawn and lungs were removed, minced and digested in the presence of excess unlabelled anti-GR-1 to prevent possible binding of the injected antibody to extravascular PMN. A cell suspension was prepared by passing the digested lungs through a 70 mm cell strainer (BD Falcon, Bedford, MA, USA). Total cells in BALF and lung were counted and percentage of PMNs determined by flow cytometry. In the BALF, PMNs were identified by their typical appearance in the forward/sideward scatter and their expression of CD45 (clone 30-F11), 7/4 (clone 7/4), and GR-1 (clone RB6-8C5). In the lung, the expression of GR-1 was used to distinguish intravascular (CD45+7/4+GR-1+) from interstitial (CD45+7/4+GR-1-) PMNs, which were not reached by the injected antibody. In all experiments, isotype control antibodies were used to set the gates.
Cytospins of BALF Cytospins of BALF from wild-type and PI3Kc -/-mice harvested 24 h after LPS exposure were prepared using a cytocentrifuge (Thermo Shandon, Waltham, MA, USA). Cytospun cells were stained (Diff-Quick staining; IMEB Inc., San Marcos, CA, USA), air dried and coverslipped.
Pulmonary microvascular permeability Pulmonary microvascular permeability in wild-type and PI3Kc -/-mice was determined by measuring extravasation of Evans blue dye [28] . Evans blue (20 mg?kg -1 ; Sigma-Aldrich, St Louis, MO, USA) was injected intravenously 30 min prior to euthanasia. Lungs were perfused with cold PBS through the spontaneously beating right ventricle to remove intravascular dye. Lungs were removed and Evans blue was extracted as previously described [29] . The absorption of Evans blue was measured at 620 nm and corrected for the presence of haem pigments: A620(corrected)5A620-(1.4266A740+0.030) [30] . Extravasated Evans blue was determined in the different animal groups 6 h after LPS (peak of LPS-induced increase in microvascular permeability) or saline inhalation and calculated against a standard curve (microgrammes Evans blue dye per gramme lung). In additional experiments, wild-type mice were pretreated with AS-605240 (50 mg?kg -1 i.p.) and microvascular permeability was determined.
BALF protein
We measured LPS-induced accumulation of protein in the BALF of wild-type mice as an indicator of epithelial permeability. 6 h after LPS, protein in the BALF was determined by a colorimetric method against a standard curve according to the manufacturer's direction (bicinchoninic acid; Thermo Scientific, Rockford, IL, USA). Some mice were pretreated with AS-605240 (50 mg?kg -1 i.p.).
Statistical analysis
Statistical analysis was performed with JMP Statistical Software (version 7.0; SAS Institute Inc., Cary, NC, USA). Differences between the groups were evaluated by one way ANOVA followed by a post hoc Tukey test. Data were presented as mean¡SD and p,0.05 was considered statistically significant.
RESULTS
Blood counts
To reveal potential PMN count alterations in the PI3Kc -/-mice, baseline differential blood counts were determined using an automatic analyser. ; nonsignificant). Consistent with a defect in transepithelial migration, intravascular and interstitial PMN counts were elevated in these mice ( fig. 3a and b) . It is possible that neutrophils get ''backed up'' in the intravascular and interstitial compartment when their transepithelial migration is impaired in PI3Kc -/-mice. When PI3Kc -/-mice were reconstituted with bone marrow from wild-type mice, transepithelial migration was only partially restored (1.6¡0.3610 6 versus 2.4¡0.5610 6 in mice that express PI3Kc on all cells; p,0.05; fig. 3c ). Intravascular and interstitial PMN counts in PI3Kc -/-mice reconstituted with bone marrow from wild-type mice were not different from wild-type mice reconstituted with bone marrow of wild-type mice, but significantly less than in mice of the negative control group or in PI3Kc -/-mice. This finding supports the hypothesis that PI3Kc on nonhaematopoietic cells is involved in transepithelial migration of PMNs.
AS-605240 inhibits in vitro transmigration
To evaluate its efficiency to inhibit chemokine-induced PMN migration in vitro, we incubated PMNs from wild-type C57Bl/ 6 or PI3Kc -/-mice with the small-molecule PI3Kc inhibitor AS-605240 (15 mM), and allowed them to migrate through a Transwell filter. Migratory activity of PI3Kc -/-PMNs was significantly reduced compared with wild-type PMNs. AS-605240 reduced CXCL2/3-stimulated migration of wild-type but not of PI3Kc -/-PMNs by .60% (p,0.05 versus untreated control) ( fig. 4a) , confirming a specific effect of AS-605240 on this subtype of PI3K. Baseline differential cell counts were performed in phosphoinositide 3-kinase gene-deficient (PI3Kc -/-) and wild-type (PI3Kc +/+ ) mice using an automatic analyser.
Next, we sought to determine the effect of AS-605240 on PECs versus PMNs. PECs were grown to confluence, and CXCL2/3-induced transendothelial PMN migration was measured. PMNs, PECs or both cell types were pretreated with the PI3Kc inhibitor as indicated.
CXCL2/3-stimulated migration through the endothelial layer was significantly reduced when PMNs were pretreated with AS-605240 (.50% reduction; p,0.05 versus untreated control; fig. 4b ). No effect was observed when PECs were pretreated with the PI3Kc inhibitor. When both PMNs and PECs were pretreated simultaneously, migration was similar to wells in which only PMNs were pretreated, indicating that PI3Kc in PMNs but not in endothelial cells is required for chemokineinduced endothelial transmigration ( fig. 4b ).
Our in vivo experiments implicated a distinct role of PI3Kc for the transepithelial migration. We therefore hypothesised that blocking PI3Kc in A549 cells would reduce transepithelial PMN migration in vitro. CXCL2/3-induced transepithelial migration was significantly reduced when PMNs were pretreated with AS-605240, similar to the transendothelial migration (46% reduction; p,0.05 versus untreated control; fig. 4c ). When PI3Kc was blocked in A549 cells alone, PMN migration was reduced by 26% (p,0.05 versus untreated control). This was in contrast to our findings with endothelial cells where blocking PI3Kc did not affect migration and supports our hypothesis that epithelial PI3Kc is involved in PMN trafficking in the lung. Blocking PI3Kc in A549 cells and PMNs did not further decrease migration, indicating that PI3Kc on PMNs limits PI3Kc-dependent trafficking in our system. This is in line with our in vivo findings ( fig. 3c ).
To reveal potential species differences with respect to PI3K-dependent transmigration of PMNs, we repeated the in vitro transmigration assays with HPMECs. In analogy to our findings with murine cells, inhibition of PI3K in HPMEC did not affect PMN migration ( fig. 4d ), suggesting that both species are comparable. ; p,0.05; fig. 5 ). The inhibitor did not reduce recruitment of PMNs to the pulmonary vasculature or transendothelial migration into the interstitium. In addition, the inhibitor exhibited no effects on LPS-induced PMN migration in PI3Kc -/-mice, supporting its specificity for PI3Kc.
Effects of AS-605240 on in vivo transmigration
Microvascular permeability and BALF protein
Disturbance of endothelial integrity and efflux of protein-rich fluid into the lung tissue is one of the critical events in the early development of ARDS that accompanies PMN infiltration. We therefore determined the role of PI3Kc in LPS-induced fig. 6a ). Although both baseline and LPS-induced microvascular permeability tended to be higher in PI3Kc -/-mice, differences were not significant. Pretreatment with AS-605240 did not prevent LPS-induced microvascular permeability in wild-type or PI3Kc -/-mice. In addition, LPS-induced protein efflux into the alveolar space was not affected by inhibition of PI3Kc ( fig. 6b ). This suggests a distinct role of PI3Kc for cell trafficking in our model.
DISCUSSION
The present study was designed to characterise the role of PI3Kc in the distinct steps of PMN trafficking in the lung. In a murine model of ALI/ARDS, PI3Kc was required for the transepithelial migration of PMNs from the lung interstitium into the alveolar airspace, while adhesion to and migration through the pulmonary endothelium remained unaffected in the absence of PI3Kc. Transmigration was mainly dependent on PI3Kc on bone marrow-derived cells, although PI3Kc on nonhaematopoietic cells contributed to the transepithelial migration of PMNs. The small-molecule PI3Kc inhibitor AS-605240 reduced PMN migration in vitro and PMN infiltration into the lung in vivo.
The key role of PI3Kc in migration of leukocytes to inflamed tissue has led to several experimental studies that sought to identify the effects of PI3Kc-involving pathways in ALI, a disease that is largely characterised by the infiltration of inflammatory cells. Consistent with the hypothesis that inhibition of PI3Kc attenuates ALI, PURI et al. [19] found that LPS-induced PMN migration into the BAL was almost completely abolished in PI3Kc -/-mice [19] . PI3Kc -/-PMNs in the lungs exhibited diminished activation of NF-kB and expression of pro-inflammatory chemokines interleukin-1b and tumour necrosis factor (TNF)-a [31] . Similar results were found in a model of ventilator-induced lung injury where blocking PI3K with a nonselective PI3K inhibitor reduced nuclear translocation of NF-kB and the release of interleukin-6 and macrophage inflammatory protein-2 in the lung [15] . In a similar model, PI3Kc -/-mice exhibited less lung damage as assessed by respiratory mechanics and the formation of hyaline membranes [14] . In that study, effects of the PI3Kc pathway were independent of the release of chemotactic chemokines, but the authors observed an increased apoptotic activity in pulmonary cells of PI3Kc -/-mice while cell necrosis was reduced in these mice.
The role of the PI3K pathway in mediating apoptosis is well established [32] . However, the role of apoptosis in the pathophysiology of inflammatory diseases remains controversial. Increased apoptosis, particularly in lymphoid tissue, contributes to immune suppression and organ failure that occurs during sepsis [33] . Conversely, apoptosis, in contrast to necrosis, generally does not produce inflammation and tissue damage [34] . In lung injury, cell necrosis rather than apoptosis is associated with an inflammatory response and inversely correlates with lung function [35] . In addition, PI3Kc-dependent pathways seem notably important for the integrity of the alveolar epithelium [36] , consistent with our finding that PI3Kc was mediating the epithelial but not endothelial barrier function in the lung. BONNANS et al. [37] identified an endogenous PI3K inhibitory pathway that is initiated by the production of presqualene diphosphate (PSDP). In acidinduced lung injury, PSDP is suppressed and PI3Kc activity increased. Consequently, pretreatment with a PSDP analogue reduced acid-induced PMN infiltration and lung tissue damage. However, beneficial effects of PI3Kc inhibition in ALI did not remain indisputable. Not inhibition, but activation of PI3K-dependent pathways was found to promote lung epithelial repair in vitro induced by Fas-induced apoptosis [38] or mechanical injury [39] . In E. coli-induced sepsis, pulmonary PMN accumulation and microvascular permeability was pronounced in PI3Kc -/-mice and associated with increased expression of CD47 and b 3 -integrins [16] . Consistent with our findings, the authors observed increased PMN counts in the lung interstitium by using morphometric analyses and suggested that upregulation of the CD47-associated b 3 -integrin complex led to increased adhesion of PMNs within the extracellular matrix and accumulation of PMNs in the lung interstitium. Transepithelial migration into the BALF was not determined in that study. In endotoxaemic mice, nonspecific PI3K inhibition led to a state of hypercoagulation, increased release of cytokines and, most notably, increased mortality [40] . In addition, anti-inflammatory effects of lipoic acid or glucan phosphate, both stimulating the PI3K pathway, were abolished when PI3K signalling was blocked [41] , indicating that the PI3K pathway is a physiological inhibitor of inflammation in endotoxaemia and sepsis. In a model of S. pneumoniae-induced lung inflammation, bacterial clearance was significantly reduced when PI3K signalling was inhibited, most likely due to a defect in respiratory burst and insufficient production of reactive oxygen species [17] . In addition, PI3Kc -/-mice failed to sufficiently recruit monocytes into the lung while PMN trafficking remained unaffected, confirming cell-specific effects of PI3K signalling observed by others [42] .
The activation of multiple PI3K-dependent pathways with opposing effects might be one explanation for the apparent discrepancies seen in lung injury in different studies [14, 16, 17, 40, 43] . It is also important to mention that so far, the use of nonselective PI3K inhibitors such as wortmannin or LY294002 hampered the validation of the PI3Kc pathway as a therapeutic target.
Signalling of endothelial PI3K is known to mediate cell migration, vascular permeability and angiogenesis [44, 45] and has, therefore, been implicated as a promising target in various malignant diseases [46] . However, involvement of endothelial PI3Kc in inflammatory responses has been controversial. PI3Kc was not required for TNF-induced upregulation of NF-kB in human umbilical vein endothelial cells (HUVECs) [47] . Others, however, demonstrated PI3Kc-dependent NF-kB binding to the intercellular adhesion molecule (ICAM)-1 promoter in pulmonary microvascular endothelial cells that was required for static adhesion of PMNs [48] . Chemokine-induced leukocyte adhesion was reduced in PI3Kc -/-mice and in lethally irradiated wild-type mice that had been reconstituted with bone marrow from PI3Kc -/-mice [49] . Interestingly, impairment of adhesion was not as severe when PI3Kc -/-deletion was confined to bone marrow-derived cells (50% versus 80% reduction), underlining a contribution of nonleukocyte PI3Kc. In our model, PI3Kc-deficiency led to a three-fold increase in intravascular PMNs in the lungs. Several reasons may have contributed to this discrepancy. 1) SMITH et al. [49] tested the role of PI3Kc in P-selectin-dependent adhesion. In our model, adhesion to the pulmonary microcirculation is Pselectin-independent (unpublished observation). 2) Cell trafficking in the systemic circulation differs substantially from the pulmonary microcirculation. Adhesion in the small pulmonary capillaries occurs largely independent of adhesion molecules and chemokines. 3) SMITH et al. [49] found that PI3Kc was essential to keep leukocytes attached to post-capillary venules within a period of 60 s. In the lung, PMNs reside for a much longer time before they are released back to the circulation or migrate into the lung (1-2 h) [26] . Short time effects have not been investigated in the present study. 4) It is important to recognise that accumulation of PMNs in the pulmonary circulation is directly related to the migratory activity of these cells. Reduced migration into the alveolar space will increase numbers of PMNs in upstream compartments, i.e. interstitium and intravascular space.
In addition, endothelial but not leukocyte PI3Kc mediated TNF-a-induced PMN adhesion to cremaster muscle venules, and nonleukocyte PI3Kc contributed to LPS-induced migration of PMNs into the BALF [19] . E-selectin-mediated adhesion of PNMs to cremaster muscle venules was almost completely abolished when PI3Kc was absent on endothelial cells [19] . Others confirmed a role for PI3Kc in chemokine-induced PMN transmigration but did not observe PI3Kc-dependent adhesion and rolling [50] . In the present study, compartmentalisation of PMN trafficking in the lung revealed that adhesion to and transmigration through the pulmonary endothelium did not require PI3Kc. Consistent with these findings, we found no effects when PECs were treated with AS-605240 in vitro. Although migratory activity was reduced when PI3Kc was blocked in PMNs, the inhibitory effect of AS-605240 on neutrophil migration through an endothelial monolayer was comparable to that seen without monolayer. These studies indicate that PECs do not significantly contribute to PI3Kc-mediatied PMN migration. In contrast, blocking PI3Kc in human pulmonary epithelial cells significantly reduced PMN migration in an in vitro transmigration system ( fig. 4c ). This supports our hypothesis of a distinct role of epithelial PI3Kc in pulmonary leukocyte trafficking.
In addition, PI3Kc -/-mice had significantly higher PMN counts in the intravascular space than wild-type mice (figs 1b and 2a). This increased availability of intravascular neutrophils may have contributed to increased migration of PMNs through the endothelial barrier in PI3Kc -/-mice. However, transepithelial migration into the alveolar airspace was significantly reduced when PI3Kc was absent. The defect was prominent in PI3Kc -/-mice and remained when PI3Kc function on leukocytes was restored. The mechanisms that link nonleukocyte PI3Kc-signalling to the recruitment of inflammatory cells are not fully understood, but PI3K-dependent activation of adhesion molecules appears to be involved. In HUVECs, cytokineinduced expression of ICAM-1 and vascular cell adhesion molecule-1 involves PI3K-signalling [51] . Others, however, demonstrated that PI3K rather suppressed the expression of adhesion molecules on endothelial cells [52] . ICAM-1 is a critical mediator in LPS-induced lung injury [7] . It is worth mentioning that ICAM-1 on alveolar and bronchial epithelium significantly contributes to inflammatory leukocyte recruitment to the lung [53] . PI3K deletion may reduce epithelial ICAM-1 expression and result in disturbed transepithelial migration that has been observed in our study. Additional mechanisms of nonleukocyte PI3K-signalling in inflammation include activation of heat shock protein 70 [54] and release of reactive oxidant species [48] .
In summary, our study reveals a differentiated role of PI3Kc signalling in LPS-induced PMN trafficking in the lung. Our findings point to a specific role of PI3Kc for the transepithelial migration into the alveolar space that involves PI3Kc on nonhaematopoietic cells. A small-molecule PI3Kc inhibitor effectively reduced PMN transmigration but did not reduce LPS-induced microvascular permeability. Further investigations are required to determine its therapeutic potential in ALI.
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